9th Annual Biomarkers Congress

Antibodies: Merck

Total Score People Score Events Score
27 24 18
Date Event Presentation Speakers
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Path to clinical development of Anticalins and other new scaffolds Laurent Audoly
May 17, 2010 Immunogenicity of Therapeutic Biologics Chairpersons’ Opening Remarks Laurent Audoly
May 4, 2010 Biomarker World Congress 2010 Identification of a Transcriptional Biomarker of Target Engagement and Use in Oncology Early Clinical Development Samuel C. Blackman
Practice and Pitfalls of Open Source Precompetitive Collaboration on Biomarkers John A. Wagner
From Biomarker Strategies to Biomarker Activities and Back Alain van Gool
April 30, 2010 Drug Story Dll4 and Notch1 Antagonist Antibodies Inhibit Yan Wu
October 6, 2009 Phage Display to Develop Therapeutic Antibodies Strategies for a Competitive Biologics Portfolio Georg Feger
January 12, 2009 Model Based Drug Development KEYNOTE PRESENTATION : The Use of Decision Analytic Paradigms to Reduce Uncertainty in Drug Development Anis Khan, Rajesh Krishna
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics New(er) Tools for Rapid Metabolite Identification Kevin Bateman
Minimizing Drug Toxicities During Drug Discovery and Development | Altas Ballroom (Town & Country/San Diego) Tom Baillie
Unusual Interspecies Differences in the Metabolism of a Cathepsin K Inhibitor Deborah Nicoll-Griffith
Unusual Interspecies Differences in the Metabolism of a Cathepsin K Inhibitor Deborah Nicoll-Griffith
July 20, 2008 WORLD SUMMIT OF ANTIVIRALS Combating Severe Viral Infections Session 6: Omics and System Biology for Viral Infectious Diseases Xiaohua Douglas Zhang
Analytic Methods in Genome-Scale RNAi Research with Applications in Drug Discovery for Viral Infectious Diseases Xiaohua Douglas Zhang
May 4, 2008 Impact China IV: Pharmaceutical R&D Global Summit Keynote Address: Chinese SFDA and Global Drug Development - Quality, Science and Speed Zili Li
Elective: Track A: Novel Advancements and Developments Originating in China: Engineering Anti-ADDLs Antibodies for Treatment of Alzheimers Disease Zhiqiang An
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
April 27, 2008 Phage Display of Antibodies and Peptides Dll4 and Notch1 Antagonist Antibodies Inhibit Tumor Growth by Deregulating Angiogenesis Yan Wu
March 31, 2008 China 2008 Pharmaceutical R&D Summit Track I Discovery to PreClinical Development –Case studies of Licensing & Partnering in China Chairperson’s Opening Remarks Dr. Bharatt M. Chowrira
March 9, 2008 NEW ANTIBACTERIAL DISCOVERY & DEVELOPMENT New strategies to develop novel targets: Platensimycin, a selective FabF inhibitor Sheo B Singh
February 17, 2008 GRC - Peptides, Chemistry & Biology Of Ligands for Melanocortin Receptors Maria Bednarek
November 29, 2007 Fourth Annual In Vivo Molecular Imaging: Bridging the Gap from Discovery to Clinical Applications Nov (29-30) Pre-Clinical Imaging (08:25-12:15) John Atack
Pre-Clinical Imaging: PET Imaging and Occupancy Measurements in Rat, Monkey and Humans (08:30-09:00) John Atack
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Assessing Structure/Function Relationships (08:15-10:45) Michael W. Washabaugh
Assessing Structure/Function Relationships :Assessing Product Potency & Related Characteristics of Gardasil,® a Recombinant HPV Vaccine (09:45-10:15) Michael W. Washabaugh
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) David Wohlpart
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:45-10:15) David Wohlpart
Impact of Extractables and Leachables on Well Characterized Protein Products (10:45-13:25) John P. Hennessey
Emerging Analytical Technologies (13:25-15:30) John P. Hennessey
Emerging Analytical Technologies: Chairperson's Remarks (13:25-13:30) John P. Hennessey
Process and Analytical Related Issues: Specifications - The Interface between Clinical, Analytical, and Process (16:00-16:30) Timothy , Schofield
Process and Analytical Related Issues (15:30-17:00) Timothy , Schofield
November 7, 2007 Antibodies Europe: Engineering the Next Generation of Antibodies Nov (07-08) Engineering for Optimum Performance and Yield (16:15-19:15) Ping Zhong
Engineering for Optimum Performance and Yield: Antibody Optimization by AISIM Technology (17:45-18:15) Ping Zhong
November 1, 2007 Characterization and Comparability for Complex Biological Products Characterization & Comparability of a Recombinant HPV Vaccine Michael W. Washabaugh
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.